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Background. The influence oflow doses ofaflatoxin 8} (AFBI) Will partial hepatectomy
(PH) on 8Iuhtrllion~ ·S· tr'lII .if(·rase (CST) acrh'iry wns SfUdieci in rllt' plasma llIld U\'cr Uf l 'H ~
rat. Methods. The animals were divided into fou groups. The firs! (/J and the second (/I)
group were treated with AFBrfreshly dissolved in dimethyl sulphoxide (DMSO). and ad-
ministered as a single intraperitoneal dose of50 jlg/ral 24 hrs after the rats had undergone
either shom operation or. 40% PH respectivdy. 711t' third group (Ill) of animals was
treated with a total dose of I mg AFBr -5days per week during a period of 8 weeks. TI,e
non-treated animals were used as controls (e). Results. We observeda significant increase
ofCST activity in the plasma of all experimental groups compared 10 the controls (C).
(1'<0.02101'<0.005). In the liver. the CSTactivity ofall experimental groups was also sig-
nificantly increased. compared 10the controls (from 1'<0.02 10 p<0.OO5). Conclusion. TI,e
administration ofboth single and multiple (loses ojAFBI Jed to long term increase ofCST
activity in till' rat plasma and liver, and partial hepatectomy had 11 0 significant effect 011
this phenomenon.
Key wor d s: utlutoxlns: ra rcino~ens; glutathione transfcruse; liver-;
plasma; rats.
Introduction
Aflatoxins are widely distributed in the nature and the
most important of these closely related mycotoxins is afla-
toxin BI (AFBd, which is a metabolite of certain Aspergil-
lus species (A. flavus and A. parasiticus}. These arc wide-
spread fungi, which can contaminate animal and human
fooO (1). It is known that AFB I is hepatotoxic and hepato-
carcinogenic in many animal species. including rats (2. 3),
and also humans (4). The liver is an important target of the
toxicity of drugs. xenobiotics and oxidative stress (5). Many
chemical compounds are modified by liver extracts to yield
active compounds (among these arc epoxides), and their ac-
tions arc usually directed to macromolecules such as DNA
(6, 7). In order to exen its biological effects (acute toxicity,
reratogenecity, mutagenicity and carcinogenicity), AFB I
must be convened to its reactive cpcxlde (Figure 1) by cy-
tochrome P450 enzyme system of liver and several other
tissues of different animals (8. 9). The epoxide is highly re-
active, and can form derivatives with several cellular mac-
romolecules. including DNA. RNA. and proteins. It is be-
lieved that covalent interaction of epoxide with DNA is re-
sponsible for the initiation of carcinogenesis followed by
the subsequent step of promotion and progression. and that
it leads to cancer formation (7).
Hepatic antioxidants represent the major defence
against toxic liver injury. and they act J.O;; anrl-apopronc
agents (10).
With respect to the capacity for AFB, oxidation, srnk-
ing differences exist among microsomes prepared from dif-
Strelic NJ. et al. Vojnosanit PregI2003; 60(4): 415-420.In ourexperiments we observed a significant increase
of GST activity in the plasma of all three experimental
groupscompared to controls. as presentedinFigure2.
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further analysis. All chemicals were the
products of Sigma (St. Louis. MO. USA).
Fresh blood was immediately collected us-
ing heparin (1000 Ulml) as anticoagulant.
Aliquots of blood were taken immediately
after exsanguinations and centrifuged for
the separation of plasma. For the determi-
nation of GST activity in the plasma and
liver l-chloro-z.a-dinitrobenzene (CDNB)
was usedas a substrate (17). Protein content
was determined by the method of Lowry et
al. usingbovineserum albumin asa referent value (18).
The obtained data were statistically analyzed and ex-
pressed as mean values ± SE. and differences between the
experimental andthe control group were estimated by Stu-
dent'sr-tcst (19). The value of p<O.05 was considered sta-
tisticallysignificant.
BOJHOCAHIITETCKII n PEr J1E.lJ.
o
OMe
AFI.ATOXIN H, AFLATOXIl'i H,· 8,9 ~:J'OXID E
FiJ.:. I - Conversion of aflatoxinBI to aflatoxin8 1- 8.9 epoxide intheliver
fcrent species. Human liver microsomes are approximately
one-fourth as efficient in activating AFB, as rat micro-
somes. For manyyearsit hasbeen perceivedthat the mouse
and rat. though closely related. respond in a completelydif-
ferent way to hepatocarcinogenic effects of aflatoxin HI
(I I). Mouse microsomes have higher specific activity for
AFBl-8.9-epoxide (AFBO) production than rat rnlcrosomes.
but arc resistant to the hcpatocarcincgcnic effects of AFB,
because of the efficient conjugation of AFBO with glutathi-
one (GSH) (12. 13). Glutathione-Svtransferase (GST) is in-
volved in detoxification of epoxides through conjugation
between GSH and AFB, (14). GST is found in cytosol of
cells in vertebrates, plants. insects. nematodes. yeasts. and
aerobic bacteria. Inmammalianorganisms GST is present in
all tissues. hutthe highest activity of this enzyme was found
in the liver. representing up to 10%of totalproteinamount.
GST activity might be a key factor in determining in-
dividual or species susceptibility to AFBIo and the major
route of detoxification of AFB1 via conjugation of AFBO
withGSH is inrodents. noticeably.
Satoh et of. showed that hepatectomy enhanced tumor
development in rats given chemical carcinogencs (15).
The aim of this study was to investigatethe influence
of low doses of AFB, and partial hepatectomy (PH) on GST
activityinthe plasmaandliverof therats.
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Methods
Male rats of the inbred Albino Oxford (AO) strain
(~-6 weeksold) wereused in (heexperiment. Animalswere
kept in wire-bottomed cages underthe standardized condi-
lions of humidity. light and temperature at the Institute for
Medical Research of the Military Medical Academy. Food
andwater weregiven at/libitum.
The animals were divided into four groups. The first
(I) and the second (II) group were treated with AFB, freshly
dissolved in dimethyl sulphoxidc (DMSO). administered as
a single intraperitoneal dose of 50 ug/rut (24 hrs after the
rats underwent a shamoperation. or40% PH. respectively).
The third group (III) of rats was treated with a total dose of
I mg AFB1 • 5 days per week during 8 weeks. Non treated
animals wereused as the controls (C).
Partial hepatectomy was performed according to the
technique of Higgins and Anderson (16). The animals were
sacrificed 13-1 5 months after the administration of AFn l.
The livers were excissed within 3 minutes and prepared for
Flg. 2 - Changes ofgfuunhionc-Suransferusc (GST)
activityin theplasma ofrats sacrificed 13-15 months after
AFB.treatment.
AFB,was administered intrapcritoneally to nusin thesingledose of 50
IltUral 24 brs aftertherats underwent 3 sham operation (I)or..w%
Q3nial hepatectomy (II) andin multiple doses 5 day!iJwcck. (lotaldoses
of 1mgAFB, in8 weeks)(III). Norureared animals represcmed
controls(C).The number of animals isgi·..en in parentheses.
The sham operated rats 2.. hrs before the treatment
withAFB1showed lower than 2-fold increasein GST activ-
ity. compared to the control value (p<O.02). The most sig-
nificanl increase (near 2-fold. p<O.OO5) was in the group of
rats II which underwent hepatectomy 24 hrsbefore the sin-
gle treatment with AFBI.Thc highest increase in GST activ-
ity in plasma was detected in the group of rats III, which
were treated for two months with I mg of AFB I .IS a total
dose (2.5-fold. p<O.OI).
Changesof GST activity in the liver of the ruts treated
by APB1 are presented in Figure 3A and 30. A significantEpoj4 BOJIIOCAHIITETCKI1 nrsrnen erp.II.417
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increase (p<O.O I) of specific activity of aST from group II
was found in comparison to the control animals (Figure
3A). \Vhen the activity of GST was expressed in gram of
the wet mass of tissue (Figure 3B) the values were more
significant in all three experimental groups of animals in rc-
spcct to the control rats (p<O .O I and 1'<0.(05).
Fig. 3 - Changes of glutarhlonc-Saransferase (GSn activity in
the liver of rats after AFBllrealmcnl
ArBl was administered.Intropcritoncnlly to the rats in the single dose of
50 ~glral 24 hrs after the rats underwent a sham operation (I). or 40%
partial hepatectomy (II), and in multiple doses 5 days/week (total doses
of I mg AFBI in 8 weeks) (III). Nomreared animals represented
controls (C). The numberofanimals is given in parentheses.
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(22). Many of the earlier studies showed that multiple doses
of AFB. led to the development of liver tumors in rats be-
tween the lst and the 2nd year after poisoning (23). Other
studies showed that PH combined with AFB . enhanced tu-
mor development (20).
An important detoxification pathway in animals - the
conjugation of AFB, 10 aSH (mediated by aST) and its
subsequent excretion is related to AFB. toxicity resistencc
(24). Differences in AFB. susceptibility of various species
depended on their hepatic cytosol capability to inactivate
AFBO by conjugation with aSH (25. 26). Mice occured
highly resistant to the hepatocarci nogenic effects of afla-
toxin (27). Although mouse microsomes produced relatively
more AFBO than rat microsomes under similar incubation
conditions. mice were more resistant to the hepatocarcino-
genic effects of AFB)because ofthe efficient conjugation of
AFBO with GSH (28). Liver cytosolic fractions from the
mouse had 50- to 100- fold greater AFBO conjugating ac-
tivity than those from the rat (12).
Individuals with high activity of oxidative enzymes
and/or low activity of detoxifying enzymes might be at the
increased risk for certain types ofcancers. For AFB, cancer
risk estimation. the rates of cytochrome P450 (CYP).
mediated AFB, activation. as wcll as a ST-catalyzed AFBO
-detoxification must be concidered (29).
Slone et al. (28) analyzed hepatic cytosollc fractions
prepared from 14 human donors for GST activity. Human
liver cyrosolic GST exhibited low activity towards AFRO
(0. 17·1.46IlmoVminlmg). Hepatic aST·AFBO activities of
the rat. hamster and mouse were 70-, 465-. and 3545·fold
greater. respectively. than the ones observed in human liver
using microsomally-generated AFBO.
In our experiment. total hepatic GST activities towards
AFBO measured one year after ArB. poisoning. were in-
creased 10-40%, compared to the controls.
Earlier studies (15) with purified GST from the rat liver
indicated different activity ofcertain class of this enzyme to-
wards AFBO. In the direct contrast to a large number ofother
drug-metabolizing enzymes. aST·p (subunit of neutral aST
purified from placenta) was found not to be inducible in the
livers of rats by short-term administration of drugs or car-
cinogens such as phenobarbital. a butylated hydroxyanisole.
N·2·lIuorenylacclamide. 3-methylcholanthrenc. 3'methyI4-
dimcthylaminoazobcnzene. However, two chemical carcino-
gens diethylnitrosarninc, and N·2-fluorenylacetamidc. plus
partial hepatectomy induced prencoplastic foci and hyper-
plastic nodules in rat liver and elevated the amounts ofGST-P
30-50 limes. compared 10 normal liver (15). On the basis of
their results, Satoh et of. concluded that GST-P might beex-
peered to have a crucial role in relation to the resistance
mechanism or, more directly, to the growth of preneoplastic
cells.
Liu et 01. (30) found persistent expression ofaST-p in
all the livers of AFBI -treatcd rats during three time inter-
vals (I. 3, and 12 months) after AFB. poiso ning. Since there
were no liver tumors induced within one year after AFB,
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Different studies in rats have demonstrated the potent
toxic and carcinogenic effects of aflatoxins (2). Despite the
differences. (different sources of aflatoxin - food contami-
nated with AFB 1 or purified AFB!> different routes of ad-
ministration. different periods of administration and obscr-
Val ion. different basic diets and different strains of rats). all
of these studies found that aflatoxin was a very potent he-
patic carcinogen in rats fed for the period of 20 weeks. or
longer. A few studies found that even single. relatively high
doses were capable of producing hepatocellular carcinoma
(12). The selected doses of AFB, that were used in our
study were potentially cancerogenic (20. 21). Sublethal
doses of aflatoxins led to chronic toxicity that caused can-
cerogenic changes. Lethal dose of AFB I varied and de-
pended on strain difference. animal's age and other factorsCrpana 418 BOJHOCAHIlTETCKlI nPErnEA Epoj4
treatment, these data suggested that all AFB I -treatcd ani-
mals were at the prcneoplastic stage of hepatocarcinogene-
sis. The aST-p positive foci thought represented the popu-
lations of the ..initiated" cells with altered gene expression
(15). AFB, Induction resulted in aST-p overexpression. but
not in the expression of p53 tumor-suppressor gene that
played an important role in hepatocarcinogenesis (30).
These results suggested that the p53 gene mutation might
net have occured at this early stage of AFB, • induced
hepatocarcinogenesis,
In our experiments neoplastic nodules and hepato-
cellular carcinoma were not detected in the group of rats
II which underwent 40% PH 24 hrs before the single
treatment with AFB1 (results not presented). It occurred.
that the strain difference and the timing of AFBI admini-
stration in relation to PH might have had a critical role in
tumor development (3 1). The experiments in which rats
underwent two thirds PH, and 24 brs later received 0.25
mg/kg body weigh' of AFB,. showed a significantly
higher incidence of hepatocellular carcinoma. compared
to non-hepatecto mized rats sacrificed between the 55th
and the 65th week (20). Mortality during AFB, admini-
stration was much lower when the rats underwent a one
third hepatectomy (40%), than in the experiment in which
more extensive hepatectomy was performed (70%) (31).
In our experiments the mortality from hepatectomy was
70 % in AFB,- lreated rats.
In almost all the experimental systems. multiple dosing
AFB I was required for carcinogenicity (13). A single ad-
ministration of AFB1to the rats resulted in maximum liver
AFB1-DNA adduct levels 2 hrs after poisoning. The rapid
removal of these adducts (88% after 24 hrs) might be re-
lated to the requirement for multiple exposures to AFB I for
the induction oftumors in the fischer rats (21).
The effect of chronic adrninistnuion of AFOI on GST
(hepatic phase II metabolizing enzyme) was measured one
year after poisoning in the group III of animals treated with
total dose of I mg AFB,- 5 days/week in the period of 8
weeks. GST activity was significantly increased after multi-
ple doses ofAFB,.
Guerre el al. (32) reported a significant decrease in
cytosolic GST in a rabbits sacrificed 2.$ hrs after the last
oral administration (0.10 mg/kg AFB, for 5 days). In rats
GST activity measured with CDNB as a substrate occured
unaffected by such a treatment. suggesting differences in
the rat GST sensitivity to AFB1 compared to the rabbit
(33).
A variety of dietary factors have been shown to influ-
ence the carcinogencty of aflatoxin. \Vang et al. (3.$) have
found that crocetin (a natural carotenoid) enhanced GST
activity in rat liver and protected against the AFD I hepato-
toxicity . The incidence of liver lesions in male Wistar rats
treated with AFB, (total dose of 1.125 mg/ral) und crocetin
was significantly reduced (for 40%) in respect to the ani-
mals treated with AFB 1alone.
Conclusion
Consistent with the obtained data we concluded that
the administration of both single and multiple doses of
AFBI led to a long time increase of GST activity in the rat
plasma and liver, and that partial hepatectomy had no sig-
nificant effect on this phenomenon.
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PROMENE U AKTIVNOSTI GLUTATION-S-TRANSFERAZE U PLAZMII
JETRI PACOVA INOUKOVANE AFLATOKSINOM B,
uvod. Ispitivan je uticaj niskih doza aflatoksina B, (AFB,) i parcijalne hepatek-
tomije (PH) na aktivnost glutation-S-transferaze (GST) u plazmi i jetri pacova.
Metode. Livotinje su podeljene u celiri grupe. Prva (I) i druga (II) grupa su trel·
rane AFB, prethodno sveze raslvaranim u dimetilsulloksidu (OMSO) i davanim u
jednoj intraperitonealnoj dozi od 50 I1g po pacovu (24 easa posle izvrsene tazne
operacije iii 40% PH). Treca grupa (III) bila je tretirana ukupnom dozom od 1 mg
AFB.. pel puta nedeljno tokom osam nedelja. LivOlinje koje nisu lretirane prEd·
stavljale su kontrolnu grupu (C). Rezultatl. Znacajno povecan]e GST aktivnosli
(1'<0,02 - 1'<0,005) u poredenju sa kontrolnom grupom, utvrdeno je i u plazmi i u
jetri svih ispitivanih grupa pacova. Zakljucak. Oobijeni rezultati pokazuju da jed-
nokratna, kao i visekratna primena niskih doza AFB, dovodi do dugotrajne induk-
cije aktivnosti GST u plazmi i jetri pacova, te da parcijalna hepatektomija nema
vecl uticaj na ovaj lenomen.
Iipoj4
K I] u Cnere CI : aflatokslnl; karclnogenl; glutatlon transferaze;
jetra; plazma ; pacovl.
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